miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy

Background:

• MicroRNA-449a (miR-449a) is a known tumor suppressor implicated in various cancers.
• Its specific role and molecular mechanisms in response to ionizing radiation (IR) in prostate cancer remain unclear.

Purpose of the Study:

• To investigate the function of miR-449a in prostate cancer radiosensitivity.
• To elucidate the molecular mechanisms by which miR-449a affects radiation response, focusing on the pRb/E2F1 pathway.

Main Methods:

• Overexpression of miR-449a in prostate cancer cell lines (PC-3 and DU-145).
• Assessment of cell cycle distribution, apoptosis, and radiosensitivity following X-ray irradiation.
• Analysis of key protein and gene expression, including pRb, E2F1, CDC25A, and HDAC1.

Main Results:

• miR-449a overexpression enhanced radiation-induced G2/M phase arrest and apoptosis in wild-type Rb PC-3 cells, increasing radiosensitivity.
• Mutant Rb DU-145 cells showed resistance to X-ray radiation, with miR-449a having no significant effect on cell cycle distribution post-irradiation.
• Elevated miR-449a downregulated CDC25A and HDAC1, key regulators of cell cycle progression and oncogenesis.

Conclusions:

• miR-449a acts as a crucial regulator of prostate cancer radiosensitivity by modulating the pRb/E2F1 pathway.
• The tumor suppressor miR-449a enhances apoptosis and cell cycle arrest, thereby sensitizing prostate cancer cells to ionizing radiation.